Is hippocampal volume a good marker to differentiate alzheimer's disease from frontotemporal dementia?

Journal of Alzheimer's Disease

Volumn 36, Issue 1, 2013, Pages 57-66

  De Souza, Leonardo Cruz ^a,b   Chupin, Marie ^a,b,c,d,e   Bertoux, Maxime ^a,b   Lehéricy, Stéphane ^a,b,c,d,e   Dubois, Bruno ^a,b   Lamari, Foudil ^b   Le Ber, Isabelle ^a,b   Bottlaender, Michel ^f   Colliot, Olivier ^a,b,c,d   Sarazin, Marie ^a,b,g  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d CNRS   (France)

^e Equipe Cogimage CRICM   (France)

^f SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Alzheimer's disease; frontotemporal dementia; volumetric MRI

Indexed keywords

AMYLOID; CARBON 11; PITTSBURGH COMPOUND B;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID; CLINICAL EFFECTIVENESS; EPISODIC MEMORY; FEMALE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; HIPPOCAMPAL VOLUME; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 84878831146     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122293     Document Type: Article

References (48)

1. Frisoni GB, Fox NC, Jack CR Jr., Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6, 67-77.
2. Dawe RJ, Bennett DA, Schneider JA, Arfanakis K (2011) Neuropathologic correlates of hippocampal atrophy in the elderly: A clinical, pathologic, postmortem MRI study. PLoS One 6, e26286.
3. Sarazin M, Chauvire V, Gerardin E, Colliot O, Kinkingnehun S, de Souza LC, Hugonot-Diener L, Garnero L, Lehericy S, Chupin M, Dubois B (2010) The amnestic syndrome of hippocampal type in Alzheimer's disease: An MRI study. J Alzheimers Dis 22, 285-294.
4. Csernansky JG, Hamstra J, Wang L, McKeel D, Price JL, Gado M, Morris JC (2004) Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects. Alzheimer Dis Assoc Disord 18, 190-195.
5. de Souza LC, Chupin M, Lamari F, Jardel C, Leclercq D, Colliot O, Lehericy S, Dubois B, Sarazin M (2012) CSF tau markers are correlated with hippocampal volume in Alzheimer's disease. Neurobiol Aging 33, 1253-1257.
6. Blennow K, Hampel H,Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6, 131-144.
7. Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
8. Jack CR Jr., Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DL, Johnson K, Mangin JF, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM,Weiner M, Foster NL (2011) Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement 7, 474-485 e474.
9. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
10. Hornberger M, Piguet O, Kipps C, Hodges JR (2008) Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia. Neurology 71, 1481-1488.
11. Barnes J, Whitwell JL, Frost C, Josephs KA, Rossor M, Fox NC (2006) Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol 63, 1434-1439.
12. Josephs KA, Dickson DW (2007) Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration. Neurobiol Aging 28, 1718-1722.
13. Josephs KA, Whitwell JL, Jack CR, Parisi JE, Dickson DW (2006) Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol 63, 1632-1638.
14. Frisoni GB, Laakso MP, Beltramello A, Geroldi C, Bianchetti A, Soininen H, Trabucchi M (1999) Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 52, 91-100.
15. Laakso MP, Frisoni GB, Kononen M, Mikkonen M, Beltramello A, Geroldi C, Bianchetti A, Trabucchi M, Soininen H, Aronen HJ (2000) Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease:Amorphometric MRI study. Biol Psychiatry 47, 1056-1063.
16. Lindberg O, Walterfang M, Looi JC, Malykhin N, Ostberg P, Zandbelt B, Styner M, Paniagua B, Velakoulis D, Orndahl E, Wahlund LO (2012) Hippocampal shape analysis in Alzheimer's disease and frontotemporal lobar degeneration subtypes. J Alzheimers Dis 30, 355-365.
17. Hornberger M, Wong S, Tan R, Irish M, Piguet O, Kril J, Hodges JR, Halliday G (2012) In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease. Brain 135, 3015-3025.
18. Galton CJ, Gomez-Anson B, Antoun N, Scheltens P, Patterson K, Graves M, Sahakian BJ, Hodges JR (2001) Temporal lobe rating scale: Application to Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 70, 165-173.
19. Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, Hodges JR (2007) Focal cortical presentations of Alzheimer's disease. Brain 130, 2636-2645.
20. de Souza LC, Lamari F, Belliard S, Jardel C, Houillier C, De Paz R, Dubois B, Sarazin M (2011) Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias. J Neurol Neurosurg Psychiatry 82, 240-246.
21. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456-2477.
22. de Souza LC, Corlier F, Habert MO, Uspenskaya O, Maroy R, Lamari F, Chupin M, Lehericy S, Colliot O, Hahn-Barma V, Samri D, Dubois B, Bottlaender M, SarazinM(2011) Similar amyloid-{beta} burden in posterior cortical atrophy and Alzheimer's disease. Brain 134, 2036-2043.
23. Chupin M, Gerardin E, Cuingnet R, Boutet C, Lemieux L, Lehericy S, Benali H, Garnero L, Colliot O (2009) Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI. Hippocampus 19, 579-587.
24. Chupin M, Hammers A, Liu R, Colliot O, Burdett J, Bardinet E, Duncan J, Garnero L, Lemieux L (2009) Automatic segmentation of the hippocampus and the amygdala driven by hibrid constraints: Method and validation. Neuroimage 46, 749-761.
25. Chupin M, Mukuna-Bantumbakulu AR, Hasboun D, Bardinet E, Baillet S, Kinkingnehun S, Lemieux L, Dubois B, Garnero L (2007) Anatomically constrained region deformation for the automated segmentation of the hippocampus and the amygdala: Method and validation on controls and patients with Alzheimer's disease. Neuroimage 34, 996-1019.
26. Colliot O, Chetelat G, Chupin M, Desgranges B, Magnin B, Benali H, Dubois B, Garnero L, Eustache F, Lehericy S (2008) Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 248, 194-201.
27. Bergouignan L, Chupin M, Czechowska Y, Kinkingnehun S, Lemogne C, Le Bastard G, Lepage M, Garnero L, Colliot O, Fossati P (2009) Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression? Neuroimage 45, 29-37.
28. Kim H, Chupin M, Colliot O, Bernhardt BC, Bernasconi N, Bernasconi A (2012) Automatic hippocampal segmentation in temporal lobe epilepsy: Impact of developmental abnormalities. Neuroimage 59, 3178-3186.
29. Worbe Y, Gerardin E, Hartmann A, Valabregue R, Chupin M, Tremblay L, Vidailhet M, Colliot O, Lehericy S (2010) Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome. Brain 133, 3649-3660.
30. Davatzikos C, Resnick SM, Wu X, Parmpi P, Clark CM (2008) Individual patient diagnosis of AD and FTD via highdimensional pattern classification of MRI. Neuroimage 41, 1220-1227.
31. Bian H, Van Swieten JC, Leight S, Massimo L, Wood E, Forman M, Moore P, de Koning I, Clark CM, Rosso S, Trojanowski J, Lee VM, Grossman M (2008) CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70, 1827-1835.
32. Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM (2003) Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 60, 1005-1011.
33. Blass DM, Hatanpaa KJ, Brandt J, Rao V, Steinberg M, Troncoso JC, Rabins PV (2004) Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology 63, 492-497.
34. Hatanpaa KJ, Blass DM, Pletnikova O, Crain BJ, Bigio EH, Hedreen JC, White CL 3rd, Troncoso JC (2004) Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology 63, 538-542.
35. Lippa CF, Dickson DW(2004) Hippocampal sclerosis dementia: Expanding the phenotypes of frontotemporal dementias? Neurology 63, 414-415.
36. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review. J Neurol Neurosurg Psychiatry 82, 476-486.
37. Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J (2005) Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain 128, 597-605.
38. Hornberger M, Piguet O (2012) Episodic memory in frontotemporal dementia: A critical review. Brain 135, 678-692.
39. Hornberger M, Piguet O, Graham AJ, Nestor PJ, Hodges JR (2010) How preserved is episodic memory in behavioral variant frontotemporal dementia? Neurology 74, 472-479.
40. Hodges JR,Davies RR, Xuereb JH, CaseyB, Broe M, Bak TH, Kril JJ, Halliday GM(2004) Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56, 399-406.
41. Du AT, Schuff N, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin K, Miller BL, Weiner MW (2007) Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 130, 1159-1166.
42. Wolz R, Julkunen V, Koikkalainen J, Niskanen E, Zhang DP, Rueckert D, Soininen H, Lotjonen J, Alzheimer's Disease Neuroimaging I (2011) Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease. PLoS One 6, e25446.
43. Bertoux M, Delavest M, de Souza LC, Funkiewiez A, Lepine JP, Fossati P, Dubois B, Sarazin M (2012) Social Cognition and Emotional Assessment differentiates frontotemporal dementia from depression. J Neurol Neurosurg Psychiatry 83, 411-416.
44. Funkiewiez A, Bertoux M, de Souza LC, Levy R, Dubois B (2012) The SEA (Social cognition and Emotional Assessment): A clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. Neuropsychology 26, 81-90.
45. Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, MannDM(2011) The clinical diagnosis of early-onset dementias: Diagnostic accuracy and clinicopathological relationships. Brain 134, 2478-2492.
46. Rabinovici GD, Rosen HJ, Alkalay A, Kornak J, Furst AJ, Agarwal N, Mormino EC, O'Neil JP, Janabi M, Karydas A, Growdon ME, Jang JY, Huang EJ, Dearmond SJ, Trojanowski JQ, Grinberg LT, Gorno-Tempini ML, Seeley WW, Miller BL, Jagust WJ (2011) Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology 77, 2034-2042.
47. Whitwell JL,Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, Rutherford NJ, Baker M, Knopman DS, Wszolek ZK, Parisi JE, Dickson DW, Petersen RC, Rademakers R, Jack CR Jr., Josephs KA (2012) Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 135, 794-806.
48. Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M,DeDeyn PP, Bancher C, Cras P,Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H (1999) Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology 52, 1555-1562.